Target intelligence / Profile preview

General cellular metabolic machinery

Molecular classification
Other
01

Overview

General cellular metabolic machinery refers to the integrated network of biochemical reactions and pathways, including glycolysis, the citric acid cycle, and oxidative phosphorylation, that sustain life by providing energy and biosynthetic precursors (Source: StatPearls, Physiology, Metabolism). While not a single molecular target, this machinery is frequently exploited in therapeutic contexts, particularly in oncology where metabolic reprogramming is a hallmark of cancer cells (Source: Nature Reviews Cancer, Hallmarks of Cancer: The Next Generation). Drugs often target specific nodes within this machinery, such as enzymes like lactate dehydrogenase or transporters like GLUT1, to selectively starve diseased cells (Source: PubMed, Targeting Cancer Metabolism). However, because these pathways are fundamental to all living cells, targeting them requires high specificity to avoid significant systemic toxicity and adverse effects on healthy tissues (Source: NIH, Metabolic Therapies). The complexity of these networks also means that cells can often adapt to the inhibition of one pathway by upregulating another, leading to drug resistance (Source: Cell Metabolism, Metabolic Plasticity). Consequently, modern research focuses on identifying metabolic vulnerabilities unique to specific disease states rather than affecting the machinery as a whole.

Other names
Cellular metabolismMetabolic pathwaysCentral carbon metabolismMetabolic network
02

Mechanism of action

Inhibition of specific rate-limiting enzymes or transporters within central metabolic pathways to disrupt energy homeostasis or biomass accumulation.

03

Biological functions

Energy productionBiosynthesisRedox homeostasisCell growthHomeostasis
04

Disease associations

CancerDiabetes mellitusMetabolic syndromeInborn errors of metabolismMitochondrial disease
05

Safety considerations

Systemic toxicityMetabolic acidosisOff-target effects on healthy tissuesNarrow therapeutic indexDrug resistance via metabolic plasticity
06

Interacting drugs

Metformin

4 more in the full profile.

07

Biomarkers

Blood glucose levelsLactate levelsATP:AMP ratioFDG-PET imaging (glucose uptake)

Beyond the preview

Go deeper on General cellular metabolic machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General cellular metabolic machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call